EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Modern approaches to therapeutic oligonucleotide manufacturing

R Obexer iD, M Nassir iD, E R Moody iD, P S Baran iD, S L Lovelock iD

Science · 12.04.2024 · 384 (6692)

DOI: 10.1126/science.adl4015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science, erschienen am 12.04.2024. Verfasst von R Obexer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Manchester Institute of Biotechnology, Department of Chemistry, University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Oligonucleotides. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic oligonucleotides are a powerful drug modality with the potential to treat many diseases. The rapidly growing number of therapies that have been approved and that are in advanced clinical trials will place unprecedented demands on our capacity to manufacture oligonucleotides at scale. Existing methods based on solid-phase phosphoramidite chemistry are limited by their scalability and sustainability, and new approaches are urgently needed to deliver the multiton quantities of oligonucleotides that are required for therapeutic applications. The chemistry community has risen to the challenge by rethinking strategies for oligonucleotide production. Advances in chemical synthesis, biocatalysis, and process engineering technologies are leading to increasingly efficient and selective routes to oligonucleotide sequences. We review these developments, along with remaining challenges and opportunities for innovations that will allow the sustainable manufacture of diverse oligonucleotide products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligonucleotidesChemistry Techniques, Synthetic

Substanzen

Oligonucleotides

Autor:innen und Institutionen

  • Manchester Institute of Biotechnology, Department of Chemistry, University of Manchester, Manchester, UK.
  • Department of Chemistry, Scripps Research, La Jolla, CA, USA.

ORCID-Profile: R Obexer, M Nassir, E R Moody, P S Baran, S L Lovelock

Zitieren

APA

Obexer, R., Nassir, M., Moody, E. R., Baran, P. S., & Lovelock, S. L. (2024). Modern approaches to therapeutic oligonucleotide manufacturing. Science, 384(6692). https://doi.org/10.1126/science.adl4015

Vancouver

Obexer R, Nassir M, Moody ER, Baran PS, Lovelock SL. Modern approaches to therapeutic oligonucleotide manufacturing. Science. 2024;384(6692). doi:10.1126/science.adl4015

BibTeX
@article{Obexer2024,
  author = {Obexer, R and Nassir, M and Moody, E R and Baran, P S and Lovelock, S L},
  title = {Modern approaches to therapeutic oligonucleotide manufacturing},
  journal = {Science},
  year = {2024},
  volume = {384},
  number = {6692},
  doi = {10.1126/science.adl4015}
}
Kostenlos starten →